Abstract

Periodontitis is a chronic infectious disease that destroys periodontal supportive tissues and eventually causes tooth loss. It is attributed to microbial and immune factors. The goal of periodontal therapy is to achieve complete alveolar bone regeneration while keeping inflammation well-controlled. To reach this goal, many single or composite biomaterials that produce antibacterial and osteogenic effects on periodontal tissues have been developed, which are called bifunctional biomaterials. In this review, we summarize recent progress in periodontal bifunctional biomaterials including bioactive agents, guided tissue regeneration/guided bone regeneration (GTR/GBR) membranes, tissue engineering scaffolds and drug delivery systems and provide novel perspectives. In conclusion, composite biomaterials have been greatly developed and they should be chosen with care due to the risk of selection bias and the lack of evaluation of the validity of the included studies.

Highlights

  • Biomaterials: Progress and Periodontitis is a common chronic infectious disease, and severe periodontitis affects10.8% of the population in the world [1]

  • The generally accepted pathogenesis is an imbalance of oral symbiotic microbial groups, along with host immune defense [4]

  • The purpose of this review is to summarize antibacterial and osteogenic performances, and advantages and limitations of different bifunctional biomaterials, and to provide novel perspectives for further study

Read more

Summary

Introduction

Biomaterials: Progress and Periodontitis is a common chronic infectious disease, and severe periodontitis affects. It causes irreversible damage to periodontal soft and hard tissues, including alveolar bone. The accumulation of bacteria related to periodontitis hinders tissue healing and regeneration processes [7,8]. The purpose of periodontal therapy is to realize periodontal tissue regeneration after controlling inflammation via infection clearance [13]. To reach this goal, bioactive materials with antibacterial and osteogenic properties are in constant evolution. Bioactive materials with antibacterial and osteogenic properties are in constant evolution They are classified as bioactive agents, guided tissue regeneration/guided bone regeneration (GTR/GBR). Membranes, tissue engineering scaffolds and drug delivery systems according to different patterns of action.

Biomaterials
Bioactive Agents
Tissue Engineering Scaffolds
Limitations
Drug Delivery Systems
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.